Concepedia

Tengteng Yu

TY

Statistics

Publications

20

Citations

745

H-Index

16

Active since

1940

Affiliations

Dana-Farber Cancer Institute(Current)

Institute of Hematology & Blood Diseases Hospital

Kaohsiung Medical University

Kaohsiung Medical University Chung-Ho Memorial Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Tengteng Yu is an author at Dana-Farber Cancer Institute specializing in multiple myeloma therapy, oncology, and multiple myeloma.

ORCID

Publications per year

1940–2023

20

Publications

20

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 89 citations · Full text

, , +14

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications

Yu‐Tzu Tai, Liang Lin, Lijie Xing et al. · Leukemia · 2018 · 86 citations

, , +13

The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models

Shih‐Feng Cho, Liang Lin, Lijie Xing et al. · Blood Advances · 2020 · 71 citations · Full text

, , +17

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

Lijie Xing, Liang Lin, Tengteng Yu et al. · Leukemia · 2020 · 62 citations · Full text

, , +17

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Hailin Chen, Tengteng Yu, Liang Lin et al. · Blood Cancer Journal · 2022 · 51 citations · Full text

, , +17

1–5 of 20